Radiation therapy in upper GI tract tumours.

Area of Science:

• Oncology
• Gastroenterology
• Radiation Oncology

Background:

• Unresectable upper gastrointestinal cancer presents significant challenges, with local recurrence being common even after surgery.
• Radiotherapy is a local treatment modality of interest for these tumors, but its efficacy is limited by tumor size and surrounding tissue radiosensitivity.

Purpose of the Study:

• To evaluate the palliative and survival-extending effects of radiation therapy, with or without chemotherapy, in patients with unresectable upper gastrointestinal cancer.
• To explore the potential of higher-dose radiotherapy to improve long-term survival and reduce local recurrences after surgery.
• To advocate for "investigational" use of radiation therapy, ideally in comparative studies, and further research into combined radiation and chemotherapy.

Main Methods:

• The study reviews existing data on radiation therapy for upper gastrointestinal cancers, including palliative and adjuvant settings.
• It discusses the potential benefits of moderate-dose radiation therapy, with or without concomitant chemotherapy, for palliation and survival.
• The abstract highlights the need for controlled studies to investigate higher radiation doses and combined treatment modalities.

Main Results:

• Moderate-dose radiation therapy, with or without chemotherapy, can palliate over half of patients with unresectable upper gastrointestinal cancer.
• Concomitant chemotherapy, particularly for short durations, appears to prolong median survival.
• Long-term disease-free survival is rare, even with higher radiation doses, and local recurrences remain a significant issue.

Conclusions:

• Radiation therapy offers palliative benefits and potential survival prolongation for unresectable upper gastrointestinal cancers, especially when combined with chemotherapy.
• Further high-quality, controlled studies are essential to determine optimal radiation doses, the role of chemotherapy, and the potential for increased long-term survival.
• Investigational approaches, including comparisons with no active treatment, are recommended for radiation therapy in this patient population.